Nihal Ahmad Selected Research

centrinone-B

1/2018

Centriole Overduplication is the Predominant Mechanism Leading to Centrosome Amplification in Melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nihal Ahmad Research Topics

Disease

85	Neoplasms (Cancer) 10/2022 - 02/2002
37	Prostatic Neoplasms (Prostate Cancer) 05/2021 - 01/2003
27	Melanoma (Melanoma, Malignant) 10/2022 - 04/2005
19	Carcinogenesis 01/2021 - 07/2003
16	Skin Neoplasms (Skin Cancer) 01/2020 - 04/2002
7	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2003
7	Adenocarcinoma 08/2020 - 01/2003
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020 - 08/2003
4	Carcinoma (Carcinomatosis) 05/2006 - 07/2003
3	Inflammation (Inflammations) 03/2021 - 02/2003
3	Skin Diseases (Skin Disease) 01/2020 - 09/2004
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2016 - 05/2007
3	Edema (Dropsy) 07/2007 - 01/2003
2	Body Weight (Weight, Body) 01/2022 - 01/2017
2	Nevus (Nevi) 03/2017 - 01/2017
2	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2014 - 04/2011
2	Hyperplasia 07/2007 - 07/2004
2	Prostatic Diseases 02/2004 - 01/2003

Drug/Important Bio-Agent (IBA)

31	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2003
17	ResveratrolIBA 03/2021 - 01/2003
16	Polo-Like Kinase 1IBA 01/2021 - 04/2005
15	SirtuinsIBA 01/2021 - 02/2009
15	TeaIBA 07/2009 - 02/2002
13	Phosphotransferases (Kinase)IBA 02/2022 - 01/2004
13	Sirtuin 1IBA 01/2022 - 02/2009
12	AntioxidantsIBA 08/2020 - 04/2002
9	Small Interfering RNA (siRNA)IBA 10/2022 - 04/2005
9	AndrogensIBA 08/2020 - 02/2004
9	Pharmaceutical PreparationsIBA 01/2019 - 08/2003
9	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2010 - 02/2002
8	Messenger RNA (mRNA)IBA 10/2022 - 01/2005
8	Histone Deacetylases (Histone Deacetylase)IBA 09/2017 - 02/2009
8	PolyphenolsIBA 03/2009 - 02/2002
6	Therapeutic UsesIBA 07/2013 - 04/2004
5	BI 6727IBA 02/2022 - 11/2014
5	Sirtuin 3IBA 01/2022 - 04/2016
5	Androgen Receptors (Androgen Receptor)IBA 01/2019 - 11/2014
5	CyclinsIBA 04/2016 - 07/2004
5	sanguinarineIBA 04/2015 - 08/2003
5	MelatoninIBA 03/2011 - 10/2006
5	Hormones (Hormone)IBA 01/2011 - 10/2006
5	Guanosine Triphosphate (GTP)IBA 03/2009 - 01/2003
5	NF-kappa B (NF-kB)IBA 04/2004 - 01/2003
4	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2022 - 04/2002
4	PhytochemicalsIBA 05/2021 - 03/2009
4	Transcription Factors (Transcription Factor)IBA 08/2020 - 01/2006
4	Proliferating Cell Nuclear Antigen (PCNA)IBA 07/2020 - 04/2005
4	enzalutamideIBA 01/2019 - 01/2016
4	Sunscreening Agents (Sunscreens)IBA 01/2019 - 04/2002
4	EnzymesIBA 01/2018 - 01/2003
3	BI 2536IBA 02/2022 - 01/2015
3	ZincIBA 05/2021 - 01/2014
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2005
3	PowdersIBA 07/2020 - 01/2019
3	NAD (NADH)IBA 01/2017 - 03/2011
3	tenovin-1IBA 12/2014 - 01/2014
3	Vitamin E FDA LinkGeneric 06/2014 - 11/2008
3	SeleniumIBA 06/2014 - 11/2008
3	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 03/2009 - 02/2004
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2006 - 01/2003
3	SurvivinIBA 07/2005 - 11/2004
2	5- (2- (4- bromophenyl)vinyl)- 1,3- benzenediolIBA 01/2022 - 10/2019
2	CytokinesIBA 01/2022 - 07/2009
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2021 - 06/2010
2	QuercetinIBA 08/2020 - 01/2016
2	Cyclin D1IBA 10/2019 - 04/2005
2	Caspase 3 (Caspase-3)IBA 10/2019 - 01/2017
2	Melanins (Melanin)IBA 01/2019 - 03/2017
2	Niacinamide (Nicotinamide)FDA LinkGeneric 01/2019 - 01/2014
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018 - 01/2017
2	Sirtuin 2IBA 01/2018 - 03/2017
2	beta-Galactosidase (Lactaid)IBA 09/2017 - 04/2016
2	liquid crystal polymerIBA 09/2017 - 01/2017
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 04/2016 - 08/2004
2	CarcinogensIBA 01/2016 - 01/2015
2	Metformin (Glucophage)FDA LinkGeneric 01/2016 - 01/2015
2	Antineoplastic Agents (Antineoplastics)IBA 12/2015 - 01/2015
2	AlkaloidsIBA 04/2015 - 05/2007
2	TrypsinIBA 04/2015 - 04/2014
2	InterferonsIBA 07/2009 - 04/2005
2	Insulin-Like Growth Factor I (IGF-1)IBA 03/2009 - 12/2004
2	cytoplasmic antiproteinaseIBA 04/2006 - 01/2004
2	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2006 - 12/2004
2	Cyclin-Dependent Kinase 2IBA 04/2005 - 08/2004
2	Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA 01/2005 - 01/2003
2	AcetoneIBA 01/2005 - 01/2003
2	Matrix Metalloproteinases (MMPs)IBA 12/2004 - 01/2003
1	Cell Cycle ProteinsIBA 10/2022
1	Mechanistic Target of Rapamycin Complex 1IBA 10/2022
1	erythromycin propionate-N-acetylcysteinateIBA 10/2022
1	onvansertibIBA 02/2022
1	ChemokinesIBA 01/2022
1	afimoxifene (hydroxytamoxifen)IBA 01/2022
1	VemurafenibIBA 01/2022

Therapy/Procedure

25	Chemoprevention 10/2019 - 02/2002
18	Therapeutics 02/2022 - 09/2004
7	Castration 01/2019 - 11/2014
5	Drug Therapy (Chemotherapy) 02/2022 - 05/2007
2	Immunotherapy 01/2022 - 03/2021
1	Immunomodulation 03/2021